| Trial ID: | L0395 |
| Source ID: | IRCT20180412039283N1
|
| Associated Drug: |
Losartan
|
| Title: |
: Investigation Effect of losartan on improving liver function testes in NAFLD patients ( Non Alcoholic Fatty Liver Disease)
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
NAFLD. <br>Fatty (change of) liver, not elsewhere classified;K76.0
|
| Interventions: |
Intervention 1: Intervention group: losartan 25 mg twice a day for 12 weeks. Intervention 2: Control group: placebo 25 mg twice aday for 12 weeks.
|
| Outcome Measures: |
Liver functions tests. Timepoint: liver function tests before losartan and 12 weeks after losartan. Method of measurement: laboratory.nan
|
| Sponsor/Collaborators: |
Shahid Beheshti University of Medical Sciences
|
| Gender: |
All
|
| Age: |
20 years80 years
|
| Phases: |
Phase 3
|
| Enrollment: |
250
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: We used block randomization method.each block size was 2 by 2, and in total 16 blocks were considered.the sequences fo
|
| Start Date: |
16/02/2021
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2021
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/45843
|
